Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by S. R. Gutierrez‐Ureña
Peficitinib, a JAK Inhibitor, in the Treatment of Moderate-To-Severe Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate
Arthritis and Rheumatology
Rheumatology
Allergy
Immunology
Related publications
Increase in Methotrexate Dose in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Infliximab
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Transition to Ustekinumab in Patients With Moderate-To-Severe Psoriasis and Inadequate Response to Methotrexate: A Randomized Clinical Trial (TRANSIT)
British Journal of Dermatology
Dermatology
Medicine
Pms41 - Cost-Effectiveness Analysis of Tofacitinib in Combination With Methotrexate in the Treatment of Moderate to Severe Rheumatoid Arthritis in Greece
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Comparative Efficacy of JAK Inhibitors for Moderate-To-Severe Rheumatoid Arthritis: A Network Meta-Analysis
Advances in Therapy
Medicine
Pharmacology
Genetic Polymorphisms in Key Methotrexate Pathway Genes Are Associated With Response to Treatment in Rheumatoid Arthritis Patients
Pharmacogenomics Journal
Molecular Medicine
Genetics
Pharmacology
Preliminary Study to Identify the Predictive Factors for the Response to Methotrexate Therapy in Patients With Rheumatoid Arthritis
Yakugaku Zasshi
Pharmacology
Pharmaceutical Science
A7.17 Microarray Gene Expression Profiling of Rheumatoid Arthritis Patients for Prediction of Response to Methotrexate Treatment
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Pms47 - Cost-Effectiveness of Tofacitinib Compared With Adalimumab in the Treatment of Moderate to Severe Rheumatoid Arthritis in Iran
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Effectiveness of TNF Inhibitor Treatment With Various Methotrexate Doses in Patients With Rheumatoid Arthritis: Results From Clinical Practice
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics